Study shows potential of ctDNA as biomarker for immunotherapy response in GU cancers


Albert Jang, MD, a 3rd-year internal resident physician at Tulane University, discusses the study, “Prospective Evaluation Of Circulating Tumor Dna (ctDNA) in Detecting Early Progression on Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Cancers,” which he shared at the 2022 AUA Annual Meeting.

Recent Videos
DNA | Image Credit: © -
Adri Durant, MD, and Mouneeb Choudry, MD, answer a question during a Zoom video interview
DNA helix | Image Credit: © Siarhei -
DNA strands | Image Credit: ©  Matthieu -
Keyan Salari, MD, PhD, answers a question during a Zoom video interview
Dr. Neal Shore in an interview with Urology Times
Related Content
© 2024 MJH Life Sciences

All rights reserved.